Next Generation News and Research

RSS

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies

Patent litigation remains the most commonly used generic defense strategy among pharmaceutical companies. 71% of drug companies have used legal battles to defend their patents in the past three years, according to research from pharmaceutical business intelligence firm Cutting Edge Information.

4 Nov 2004

Research speeds development of brain-controlled devices that may allow amputees and paraplegics to use their limbs

New research is speeding the development of brain-controlled devices that may soon allow amputees and paraplegics to use their limbs.

28 Oct 2004

New $22 million dollar scholarship program to recruit the next generation of public health leaders

The Johns Hopkins Bloomberg School of Public Health has established a new $22 million dollar scholarship program to recruit the next generation of public health leaders to devise new, effective interventions to improve global health.

25 Oct 2004

Findings could lead to improvements in the next generation of implantable cardioverter defibrillators

For people who suffer from a rapid heartbeat condition called tachycardia, an implanted device can usually nudge the racing blood pump back into a normal rhythm by applying electrical pulses to the heart.

25 Oct 2004

MedImmune bumps up production of FluMist vaccine

MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed production of 1.1 million doses.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Surgical remedies for snoring and sleep disorders

Like thousands of Americans, snoring keeps Dr. Kenny Pang awake at night. It’s not his own nocturnal nasal sounds, or those of his wife, that trouble Dr. Pang -- it’s the why behind the sounds.

13 Oct 2004

Barbed sutures, ultrasonic body contouring and soft tissue fillers offer patients faster results without the downtime of surgery

Patients without time for a facelift or intimidated by surgery now have more minimally invasive options that produce effective results.

10 Oct 2004

Researchers grow mouth lining into pieces of bio-bandage

University of Michigan researchers are testing a new procedure in which they can take a tiny piece of a person's mouth lining, grow it into a dollar-bill sized piece of tissue and graft that expanded piece into the donor's mouth to heal a wound.

5 Oct 2004

On-line campaign asks, where does all the breast cancer research money go?

Barbara Ehrenreich and Breast Cancer Action (BCA) have launched an online Flash movie and email campaign that exposes the lack of coordination among more than 30 federal agencies and dozens of private foundations and pharmaceutical companies funding research on breast cancer.

28 Sep 2004

New insights into ancient mating and migration patterns in humans

Men have been tomcatting around since time immemorial, and some traveled far from home to do it, new research suggests.

20 Sep 2004

Newly completed Chromosome 5 sequence will be a powerful tool for scientists trying to understand human disease

Four years after publicly revealing the official draft human genetic sequence, researchers have reached the halfway point in dotting the i's and crossing the t's of the genetic sentences describing how to build a human.

16 Sep 2004

Powdered form of anthrax vaccine could eliminate needle injections

Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.

26 Aug 2004

Researchers using light to control genes and better understand the role of certain genes in embryonic development

As our understanding of biology increases, the tools of research become almost as important as the researchers wielding them. Currently, one of the major obstacles to research is actually getting inside of cells and tissue to see what is going on as it happens.

25 Aug 2004

The next generation of single-enantiomer catalysts

Many molecules are enantiomers: they have mirror- image versions that may have identical parts but are just as different as your left hand is from your right.

23 Aug 2004

Australian funding to assist with the investigation of clandestine laboratory operations

"Clandestine amphetamine laboratories have increased by 300 per cent and it is important that forensic experts have the opportunity to work together in what is one of the most important areas in the fight against illegal drugs," Senator Ellison said.

13 Aug 2004

Bionomics BNO69 angiogenesis gene discovery published

Bionomics has announced that research conducted by Bionomics and its collaborators at the Hanson Centre of the Institute of Medical and Veterinary Science ("IMVS") in Adelaide, Australia, relating to Bionomics' proprietary angiogenesis drug target BNO69, has been published in the high ranking scientific journal Proceedings of the National Academy of Sciences USA (PNAS).

10 Aug 2004

Conclusion of a patent trial involving discontinued trocar products by United States Surgical

Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.

2 Aug 2004

BMA unhappy that OFCOM has not recommended a ban on all food advertising to children

"OFCOM's own research clearly states that TV advertising has an effect on children's eating habits, yet they refuse to recommend a ban. We are in the midst of an obesity epidemic and must use all the tools in our armoury to prevent the next generation of British children being the most obese in history."

22 Jul 2004

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.

20 Jul 2004